Cooper Cos. (COO): Price and Financial Metrics
COO Price/Volume Stats
Current price | $100.82 | 52-week high | $104.07 |
Prev. close | $100.71 | 52-week low | $75.93 |
Day low | $100.71 | Volume | 770,200 |
Day high | $101.45 | Avg. volume | 1,123,474 |
50-day MA | $96.31 | Dividend yield | 0.01% |
200-day MA | $90.50 | Market Cap | 20.04B |
COO Stock Price Chart Interactive Chart >
COO POWR Grades
- Stability is the dimension where COO ranks best; there it ranks ahead of 78.83% of US stocks.
- The strongest trend for COO is in Stability, which has been heading down over the past 26 weeks.
- COO's current lowest rank is in the Momentum metric (where it is better than 4.37% of US stocks).
COO Stock Summary
- COOPER COMPANIES INC's market capitalization of $18,021,514,330 is ahead of 88.38% of US-listed equities.
- COO's went public 38.03 years ago, making it older than 92.92% of listed US stocks we're tracking.
- With a price/earnings ratio of 61.26, COOPER COMPANIES INC P/E ratio is greater than that of about 88.99% of stocks in our set with positive earnings.
- If you're looking for stocks that are quantitatively similar to COOPER COMPANIES INC, a group of peers worth examining would be HAYN, IDT, HELE, SFM, and LULU.
- Visit COO's SEC page to see the company's official filings. To visit the company's web site, go to www.coopercos.com.
COO Valuation Summary
- COO's price/sales ratio is 5.2; this is 136.36% higher than that of the median Healthcare stock.
- Over the past 243 months, COO's price/sales ratio has gone up 1.5.
Below are key valuation metrics over time for COO.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
COO | 2023-12-29 | 5.2 | 2.5 | 63.7 | 40.9 |
COO | 2023-12-28 | 5.2 | 2.5 | 63.9 | 41.0 |
COO | 2023-12-27 | 5.2 | 2.5 | 64.0 | 41.0 |
COO | 2023-12-26 | 5.2 | 2.5 | 63.5 | 40.8 |
COO | 2023-12-22 | 5.1 | 2.4 | 62.9 | 40.4 |
COO | 2023-12-21 | 5.1 | 2.4 | 62.0 | 39.9 |
COO Growth Metrics
- The 5 year net cashflow from operations growth rate now stands at -1.82%.
- Its 4 year net income to common stockholders growth rate is now at 4.24%.
- Its 3 year net income to common stockholders growth rate is now at 121.96%.
The table below shows COO's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 3,308.4 | 692.4 | 385.8 |
2022-06-30 | 3,219.5 | 736.2 | 430.6 |
2022-03-31 | 3,139.5 | 696.1 | 948 |
2021-12-31 | 3,029.2 | 756.9 | 938.9 |
2021-09-30 | 2,922.5 | 738.6 | 2,944.7 |
2021-06-30 | 2,845 | 782.4 | 2,915.6 |
COO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- COO has a Quality Grade of C, ranking ahead of 72.46% of graded US stocks.
- COO's asset turnover comes in at 0.332 -- ranking 126th of 186 Medical Equipment stocks.
- KRMD, XENT, and BIOL are the stocks whose asset turnover ratios are most correlated with COO.
The table below shows COO's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-31 | 0.332 | 0.660 | 0.087 |
2021-04-30 | 0.339 | 0.648 | 0.093 |
2021-01-31 | 0.341 | 0.632 | 0.077 |
2020-10-31 | 0.366 | 0.631 | 0.079 |
2020-07-31 | 0.374 | 0.641 | 0.096 |
2020-04-30 | 0.399 | 0.651 | 0.122 |
COO Price Target
For more insight on analysts targets of COO, see our COO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $478.50 | Average Broker Recommendation | 1.63 (Moderate Buy) |
Cooper Cos. (COO) Company Bio
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company, publicly traded on the NYSE (NYSE:COO). With its headquarters in San Ramon, California, it has a workforce of more than 12,000 employees and consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI) which manufactures medical devices and fertility and genomic products for the women’s health care market. (Source:Wikipedia)
Latest COO News From Around the Web
Below are the latest news stories about COOPER COMPANIES INC that investors may wish to consider to help them evaluate COO as an investment opportunity.
CooperCompanies to Present at the J.P. Morgan Healthcare ConferenceSAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be availab |
CooperCompanies Sets Annual Meeting And Stockholder Record DatesSAN RAMON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Cooper Companies (Nasdaq: COO) announced today that it will hold its next annual meeting of stockholders on Tuesday, March 19, 2024. Stockholders of record as of the close of business on January 24, 2024, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors. About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving liv |
Cooper Companies' (NASDAQ:COO) investors will be pleased with their decent 37% return over the last five yearsThe main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share... |
Decoding The Cooper Companies Inc (COO): A Strategic SWOT InsightInsightful Analysis of The Cooper Companies Inc's Market Position and Future Prospects |
The Cooper Companies, Inc. (COO) Q4 2023 Earnings Call TranscriptThe Cooper Companies, Inc. (COO) Q4 2023 Earnings Conference Call December 07, 2023, 17:00 PM ET Company Participants Kim Duncan - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - CFO & Treasurer Conference Call Participants Jason Bednar - Piper Sandler Lawrence Biegelsen - Wells Fargo Jeffrey Johnson - Baird Jonathan Block - Stifel Craig Bijou - Bank of America Robbie Marcus - JPMorgan Steven Lichtman - Oppenheimer David Saxon - Needham Navann Ty - BNP Paribas Anthony Petrone - Mizuho Presentation Operator Thank you for standing by and welcome to the Q4 2023 Coope... |
COO Price Returns
1-mo | 8.41% |
3-mo | 11.92% |
6-mo | 22.81% |
1-year | 17.07% |
3-year | 5.06% |
5-year | 35.77% |
YTD | 6.56% |
2023 | 14.47% |
2022 | -21.06% |
2021 | 15.33% |
2020 | 13.10% |
2019 | 26.27% |
COO Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching COO
Want to see what other sources are saying about Cooper Companies Inc's financials and stock price? Try the links below:Cooper Companies Inc (COO) Stock Price | Nasdaq
Cooper Companies Inc (COO) Stock Quote, History and News - Yahoo Finance
Cooper Companies Inc (COO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...